98 related articles for article (PubMed ID: 23269466)
1. Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis.
Loos M; Quentmeier P; Schuster T; Nitsche U; Gertler R; Keerl A; Kocher T; Friess H; Rosenberg R
Ann Surg Oncol; 2013 Jun; 20(6):1816-28. PubMed ID: 23269466
[TBL] [Abstract][Full Text] [Related]
2. Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis.
Milito P; Piozzi GN; Hussain MI; Dragani TA; Sorrentino L; Cosimelli M; Guaglio M; Battaglia L
Tumori; 2024 May; ():3008916241256544. PubMed ID: 38819198
[TBL] [Abstract][Full Text] [Related]
3. Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials.
Qin C; Ren X; Xu K; Chen Z; He Y; Song X
Gastroenterol Res Pract; 2014; 2014():910956. PubMed ID: 25477955
[TBL] [Abstract][Full Text] [Related]
4. Impaired continence function five years after intensified chemoradiation in patients with locally advanced rectal cancer.
Horisberger K; Rothenhoefer S; Kripp M; Hofheinz RD; Post S; Kienle P
Eur J Surg Oncol; 2014 Feb; 40(2):227-33. PubMed ID: 24378010
[TBL] [Abstract][Full Text] [Related]
5. What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
Ma B; Gao P; Wang H; Xu Q; Song Y; Huang X; Sun J; Zhao J; Luo J; Sun Y; Wang Z
Int J Cancer; 2017 Sep; 141(5):1052-1065. PubMed ID: 28560805
[TBL] [Abstract][Full Text] [Related]
6. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
[TBL] [Abstract][Full Text] [Related]
7. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
Petrelli F; Trevisan F; Cabiddu M; Sgroi G; Bruschieri L; Rausa E; Ghidini M; Turati L
Ann Surg; 2020 Mar; 271(3):440-448. PubMed ID: 31318794
[TBL] [Abstract][Full Text] [Related]
8. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
[TBL] [Abstract][Full Text] [Related]
9. Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer.
Sun L; Qu J; Ke X; Zhang Y; Xu H; Lv N; Leng J; Zhang Y; Guan A; Feng Y; Sun Y
Front Microbiol; 2023; 14():1229888. PubMed ID: 37901832
[TBL] [Abstract][Full Text] [Related]
10. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy.
Stanojevic A; Samiotaki M; Lygirou V; Marinkovic M; Nikolic V; Stojanovic-Rundic S; Jankovic R; Vlahou A; Panayotou G; Fijneman RJA; Castellví-Bel S; Zoidakis J; Cavic M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895091
[TBL] [Abstract][Full Text] [Related]
11. Relationship between inferior mesenteric artery diameter and rectal cancer.
Chi F; Zhou S; Bi T; Zhao W; Wang X
Arch Med Sci; 2023; 19(3):633-637. PubMed ID: 37313205
[TBL] [Abstract][Full Text] [Related]
12. Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis.
Chen JH; Ye Q; Huang F
BMC Gastroenterol; 2023 Mar; 23(1):83. PubMed ID: 36959560
[TBL] [Abstract][Full Text] [Related]
13. Ionizing Radiation from Radiopharmaceuticals and the Human Gut Microbiota: An Ex Vivo Approach.
Fernandes A; Oliveira A; Guedes C; Fernandes R; Soares R; Barata P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142722
[TBL] [Abstract][Full Text] [Related]
14. Low anterior resection syndrome following rectal cancer surgery: are incidence and severity lower with long-term follow-up?
Parnasa SY; Chill H; Helou B; Cohen A; Alter R; Shveiky D; Mizrahi I; Abu-Gazala M; Pikarsky AJ; Shussman N
Tech Coloproctol; 2022 Dec; 26(12):981-989. PubMed ID: 36097205
[TBL] [Abstract][Full Text] [Related]
15. Are We There Yet? The Value of Deep Learning in a Multicenter Setting for Response Prediction of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy.
Wichtmann BD; Albert S; Zhao W; Maurer A; Rödel C; Hofheinz RD; Hesser J; Zöllner FG; Attenberger UI
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885506
[TBL] [Abstract][Full Text] [Related]
16. Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection.
Sakamoto W; Kanke Y; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Kono K
Fukushima J Med Sci; 2022 Aug; 68(2):89-95. PubMed ID: 35732415
[TBL] [Abstract][Full Text] [Related]
17. Robotic surgery contributes to the preservation of bowel and urinary function after total mesorectal excision: comparisons with transanal and conventional laparoscopic surgery.
Miura T; Sakamoto Y; Morohashi H; Suto A; Kubota S; Ichisawa A; Kuwata D; Yamada T; Tamba H; Matsumoto S; Hakamada K
BMC Surg; 2022 Apr; 22(1):147. PubMed ID: 35449005
[TBL] [Abstract][Full Text] [Related]
18. The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year.
Yoo RN; Kye BH; Kim H; Kim G; Cho HM
Ann Coloproctol; 2023 Feb; 39(1):32-40. PubMed ID: 35279968
[TBL] [Abstract][Full Text] [Related]
19. Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.
Li M; Xiao Q; Venkatachalam N; Hofheinz RD; Veldwijk MR; Herskind C; Ebert MP; Zhan T
Ther Adv Med Oncol; 2022; 14():17588359221077972. PubMed ID: 35222695
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety.
Song J; Wang Y; Yu H; Zheng L; Cai X; Chen Y
Comput Math Methods Med; 2021; 2021():4227650. PubMed ID: 34925539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
